FRAIL-NH在住院老年人中的同时效度和预测效度:一项探索性研究
该研究以衰弱指数(FI)为金标准,在因急性内科疾病住院的老年人(平均年龄89.4岁)中比较FRAIL-NH与FRAIL的效度。
要点
- FRAIL-NH与FRAIL同时效度均良好,但FRAIL-NH检出更多衰弱病例。
- FRAIL-NH对12个月内死亡和机构化的预测优于FRAIL。
- FRAIL在严重衰弱组存在天花板效应,FRAIL-NH较少。
核心结论
- FRAIL-NH在急性住院老年人中整体效度优于FRAIL,且天花板效应更少。
研究设计与样本
- 一项前瞻性队列研究的二次分析,纳入因急性内科疾病住院的老年人(平均年龄89.4岁)。
主要发现
- FRAIL-NH检出衰弱病例比例为79.5%,FRAIL为50.0%。
关键数值与推荐
- 已知组效度:两者均良好,FRAIL-NH在功能状态和痴呆方面的F值更大。
临床怎么用
- FRAIL-NH可考虑扩展至急性住院老年人群的衰弱评估。
局限性
- 探索性研究,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The FRAIL-NH was originally developed for frailty assessment of nursing home (NH) residents. We aimed to compare concurrent, predictive, and known-groups validity between FRAIL-NH and FRAIL, using the Frailty Index (FI) as gold standard reference. We also examined for ceiling effect of both measures in the detection of severe frailty. DESIGN: A secondary analysis of a prospective cohort study. SETTING & PARTICIPANTS: Older adults (mean age 89.4 years) hospitalized for an acute medical illness in a 1300-bed tertiary hospital. MEASUREMENTS: Baseline data on demographics, comorbidities, severity of illness, functional status, and cognitive status were gathered. We also captured outcomes of mortality, length of stay (LOS), institutionalization, and functional decline. For concurrent validity, we compared areas under the operating characteristic curves (AUCs) for both measures against the FI. For predictive validity, univariate analyses and multiple logistic regression were used to compare both measures against the adverse outcomes of interest. For known-groups validity, we compared both measures against comorbidities and functional status via 1-way analysis of variance, and dementia diagnosis via independent t test. Box plots were also derived to investigate for possible ceiling effect. RESULTS: Both measures had good concurrent validity (both AUC > 0.8 and P < .001), with FRAIL-NH detecting more frailty cases (79.5% vs 50.0%). Although FRAIL-frail was superior for in-hospital mortality [6.7% vs 1.0%, P = .031, odds ratio (OR) 9.29, 95% confidence interval (CI) 1.09-79.20, P < .042] and LOS (10 vs 8 days, P = .043), FRAIL-NH-frail better predicted mortality (OR 6.62, 95% CI 1.91-22.94, P = .003) and institutionalization (OR 6.03, 95% CI 2.01-18.09, P = .001) up to 12 months postenrollment. Known-groups validity was good for both measures with FRAIL-NH yielding greater F values for functional status and dementia. Lastly, box plots revealed a ceiling effect for FRAIL in the severely frail group. CONCLUSIONS AND IMPLICATIONS: This exploratory study highlights the potential for expanding the role of FRAIL-NH beyond NH to acute care settings. Contrasted to FRAIL, FRAIL-NH had better overall validity with less ceiling effect in discrimination of severe frailty.
引用
- Chong E, Huang Y, Chan M, et al. Concurrent and Predictive Validity of FRAIL-NH in Hospitalized Older Persons: An Exploratory Study. J Am Med Dir Assoc. 2021. PMID: 34004184. doi:10.1016/j.jamda.2021.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。